TD Asset Management’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-357,038
Closed -$532K 1466
2023
Q3
$532K Buy
357,038
+178,519
+100% +$340K ﹤0.01% 1267
2023
Q2
$407K Hold
178,519
﹤0.01% 1300
2023
Q1
$348K Hold
178,519
﹤0.01% 1318
2022
Q4
$293K Hold
178,519
﹤0.01% 1361
2022
Q3
$359K Buy
178,519
+23,600
+15% +$56.4K ﹤0.01% 1348
2022
Q2
$335K Hold
154,919
﹤0.01% 1343
2022
Q1
$575K Hold
154,919
﹤0.01% 1329
2021
Q4
$954K Buy
+154,919
New +$1.77M ﹤0.01% 1289

Other funds holding LIAN

TD Asset Management's LIAN Position: Q4 2023 in Review

TD Asset Management sold out of LianBio American Depositary Shares (LIAN) in Q4 2023, closing a stake of 357,038 shares — an estimated $532K sold.

TD Asset Management first reported a position in LIAN in Q4 2021 and held it in 8 quarters. The position peaked at $954K in Q4 2021. 29 funds tracked by Wall St. Rank hold LIAN as of Q4 2023.

  • TD Asset Management reported no remaining LianBio American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • TD Asset Management sold 357,038 LianBio American Depositary Shares shares in Q4 2023, an estimated $532K.
  • TD Asset Management first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 8 quarters.
  • TD Asset Management's LianBio American Depositary Shares position peaked at $954K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2023.

Based on TD Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.